FIELD: medicine. SUBSTANCE: invention relates to compositions consisting of great number of particles with mean diameter about from 0.25 mm to 2 mm that can be used for treatment of patients with obesity. Particles have tetrahydrolipstatin, stabilizing agent of its hydrolytic decomposition and at least one pharmaceutically acceptable excipient, not less. Stabilizing agent shows greater rate of moisture absorption as compared with that for tetrahydrolipstatin. Particles can be made as granules or micropills. Stabilizing agent is taken among the group: polyvinylpyrrolidone, lactose, their mixture, hydroxy- -methylcellulose and hydroxypropylcellulose. Particles can be used for preparing standard dosed form, for example, tablets and capsules. Particles of composition do not show ability to stick or loosen up and tetrahydrolipstatin in their composition shows good stability. EFFECT: improved properties of compositions. 15 cl, 4 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF INHIBITORS OF GASTRO- INTESTINAL LIPASE | 1998 |
|
RU2201272C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
DIPHOSPHONIC ACID-CONTAINING COMPOSITIONS | 1999 |
|
RU2207860C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING PRODRUG OF HCV POLYMERASE INHIBITOR | 2010 |
|
RU2489153C2 |
NOVEL PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2241462C2 |
PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
NEW PYRROLOCARBAZOLES | 1995 |
|
RU2162089C2 |
PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2138251C1 |
COMPOSITION WITH HIGH DOSE OF IBANDRONAT | 2003 |
|
RU2315603C2 |
PHARMACEUTICAL PREPARATION | 1994 |
|
RU2146522C1 |
Authors
Dates
2001-07-20—Published
1998-01-24—Filed